Helping HIV patients restart care after treatment breaks in Zambia
Part of Infections clinical trials.
This trial is looking for people living with HIV in Zambia who have stopped their treatment or missed clinic visits for more than 30 days. The goal is to find better ways to help you return to care and stay healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have missed your HIV medicines or clinic visit for more than 30 days.
- You are willing to give your consent in English, Nyanja, or Bemba (with help if needed).
- You are feeling well enough to talk and make decisions (no emergency or serious illness).
- You are not drunk or affected by a mental illness that would prevent clear consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for HIV drug resistance in people who have been on a specific first-line HIV medication (TLD) for at least 6 months and still have detectable virus. It aims to understand if resistance is developing so that better treatments can be planned.
This study tests whether helping men with HIV who also drink heavily can lower their alcohol use and improve how well HIV treatment works to prevent passing the virus to others. It's for men living in fishing communities in Uganda.
This study looks at people with advanced HIV disease during their first months on antiretroviral therapy (ART). It aims to understand and improve care for those who start treatment when their immune system is weak.
This trial uses health records to learn how people in Zambia access HIV care and treatments. It may help improve future HIV support and treatment planning.
This trial helps young people aged 18 to 24 living with HIV in three districts of Zambia. It aims to reduce stigma and build job skills to improve their lives.
This trial tests a program to help people with advanced HIV stay in care after being hospitalized. If you have a very low CD4 count or a serious HIV-related illness, this study may offer extra support to keep you healthy.
Hear when a new HIV Antiretroviral Therapy (ART) Adherence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.